Immunohistochemical staining (IHC) of tumor tissues showed that the changes in Cyclin D1, VEGF, and pAKT were similar to those in vitro results (Figure 9A), indicating that the combination of Rh2 with radiation could improve the therapeutic efficacy. The gene discussed is VEGFA; the disease is neoplasm.